Pennsylvania Capital Management Inc Eli Lilly & CO Transaction History

Pennsylvania Capital Management Inc

$255 Million
Q1 2025

A detailed history of Pennsylvania Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Pennsylvania Capital Management Inc holds 4,185 shares of LLY stock, worth $2.99 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

4,185

Previous 4,246 1.44%

Holding current value

$2.99 Million

Previous $3.28 Million 5.46%

% of portfolio

1.36%

Previous 1.21%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	SELL	$725.72 - $929.72 $44,268 - $56,712	-61 Reduced 1.44%	4,185 $3.46 Million
Q4 2024 Jan 24, 2025	BUY	$727.2 - $932.06 $18,180 - $23,301	25 Added 0.59%	4,246 $3.28 Million
Q3 2024 Oct 15, 2024	BUY	$772.14 - $960.02 $288,008 - $358,087	373 Added 9.69%	4,221 $3.74 Million
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $18,846 - $23,635	26 Added 0.68%	3,848 $3.48 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $17,173 - $22,976	-29 Reduced 0.75%	3,822 $2.97 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $104,512 - $123,206	199 Added 5.45%	3,851 $2.24 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $8,259 - $11,386	19 Added 0.52%	3,652 $1.96 Million
Q2 2023 Jul 18, 2023	BUY	$350.74 - $468.98 $2,455 - $3,282	7 Added 0.19%	3,633 $1.7 Million
Q3 2021 Nov 05, 2021	BUY	$221.6 - $272.71 $581,921 - $716,136	2,626 Added 262.6%	3,626 $884,000
Q2 2021 Jul 12, 2021	BUY	$180.55 - $233.54 $180,550 - $233,540	1,000 New	1,000 $235,000
Q3 2020 Oct 07, 2020	SELL	$146.22 - $169.13 $194,472 - $224,942	-1,330 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$136.42 - $164.18 $181,438 - $218,359	1,330 New	1,330 $218,000

Others Institutions Holding LLY

# of Institutions

4,384

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $678B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pennsylvania Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Pennsylvania Capital Management Inc with notifications on news.

Account

Pennsylvania Capital Management Inc Eli Lilly & CO Transaction History